Peptilogics Received Qualified Infectious Disease Product Designation from the FDA for Lead Compound PLG0206 as a Treatment for Prosthetic Joint Infection. We are very proud of our involvment with Peptilogics to help introduce a new antimicrobial compound, PLG0206, to prevent and fight surgical infection. More information can be found here.
Dr. Urish lead a clinical study at the Magee Bone and Joint Center on new methods to minimize post operative pain after total knee and hip replacement. Details can be read here.
Dr. Urish was invited to speak about current technologies with total hip arthroplasty to the World Arthroplasty Congress held in Rome in April. You can watch a version of the talk here.
Dr. Urish's group report on a new class of antimicrobial agents to fight and prevent surgical infection.
Dr. Urish has been awarded a grant from the orthopaedic research and education foundation to perform work preventing surgical site infection.